Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the 2016 UBS Global Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the 2016 UBS Global Healthcare Conference on Monday, May 23, at the Grand Hyatt New York. Sandi...

Key Takeaway: NEW BRUNSWICK, N.J. , May 9, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2016 UBS Global Healthcare Conference on Monday, May 23 , at the Grand Hyatt New York. Sandi Peterson, Executive Vice President, Group Worldwide Chairman will represent the Co

Conference Participation Details

UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , May 9, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2016 UBS Global Healthcare Conference on Monday, May 23 , at the Grand Hyatt New York. Sandi Peterson, Executive Vice President, Group Worldwide Chairman will represent the Company in a session scheduled at 9:00 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately two hours after the live webcast.
Last updated: May 9, 2016